Clinical Trials Browser

Phase 2 × Breast Neoplasms × EC regimen × Clear all

NCT01210768 2021-11-23

A Study of Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms